Novel Organoid Construction Strategy for Non-Involuting Congenital Hemangioma for Drug Validation

Researchers reported a novel non-involuting congenital hemangioma (NICH) organoid system construction and optimization process. Both HE and immunohistological staining exactly matched NICH tissue.